
    
      As long-term toxicity to many of the nucleoside medications have become known, interest has
      increased in treatment regimens that do not use these medications. This study is to assess
      the response of one such "nucleoside-sparing" therapy in patients who are showing failure to
      their initial nucleoside-containing treatment regimen.
    
  